193 related articles for article (PubMed ID: 27087531)
1. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
[TBL] [Abstract][Full Text] [Related]
2. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
3. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
Pechère-Bertschi A; Herpin D; Lefebvre H
Ann Endocrinol (Paris); 2016 Jul; 77(3):226-34. PubMed ID: 27315759
[TBL] [Abstract][Full Text] [Related]
4. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.
Bardet S; Chamontin B; Douillard C; Pagny JY; Hernigou A; Joffre F; Plouin PF; Steichen O
Ann Endocrinol (Paris); 2016 Jul; 77(3):208-13. PubMed ID: 27036860
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?
Stavropoulos K; Imprialos KP; Katsiki N; Petidis K; Kamparoudis A; Petras P; Georgopoulou V; Finitsis S; Papadopoulos C; Athyros VG; Doumas M; Karagiannis A
J Clin Hypertens (Greenwich); 2018 May; 20(5):942-948. PubMed ID: 29722113
[TBL] [Abstract][Full Text] [Related]
6. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
Zennaro MC; Jeunemaitre X
Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
[TBL] [Abstract][Full Text] [Related]
7. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
Steichen O; Amar L; Chaffanjon P; Kraimps JL; Ménégaux F; Zinzindohoue F
Ann Endocrinol (Paris); 2016 Jul; 77(3):220-5. PubMed ID: 27297451
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: who should be screened?
Monticone S; Viola A; Tizzani D; Crudo V; Burrello J; Galmozzi M; Veglio F; Mulatero P
Horm Metab Res; 2012 Mar; 44(3):163-9. PubMed ID: 22120135
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit.
Burrello J; Monticone S; Losano I; Cavaglià G; Buffolo F; Tetti M; Covella M; Rabbia F; Veglio F; Pasini B; Williams TA; Mulatero P
Hypertension; 2020 Apr; 75(4):1025-1033. PubMed ID: 32114853
[TBL] [Abstract][Full Text] [Related]
10. Who should be screened for primary aldosteronism? A comprehensive review of current evidence.
Huang WC; Lin YH; Wu VC; Chen CH; Siddique S; Chia YC; Tay JC; Sogunuru G; Cheng HM; Kario K
J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1194-1203. PubMed ID: 36196469
[TBL] [Abstract][Full Text] [Related]
11. Hypokalemia and the Prevalence of Primary Aldosteronism.
Gruber S; Beuschlein F
Horm Metab Res; 2020 Jun; 52(6):347-356. PubMed ID: 32252108
[TBL] [Abstract][Full Text] [Related]
12. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C; Houillier P; Nussberger J; Girerd X
Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
[TBL] [Abstract][Full Text] [Related]
13. Detecting and treating primary aldosteronism: primary aldosteronism.
Mantero F; Mattarello MJ; Albiger NM
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
[TBL] [Abstract][Full Text] [Related]
14. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Reznik Y; Amar L; Tabarin A
Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics.
Tang Z; Chen H; He W; Ma L; Song Y; Mei M; Luo T; Du Z; Hu J; Yang S; Cheng Q; Wang Z; Li Q;
J Neurol Sci; 2020 Jun; 413():116774. PubMed ID: 32217377
[TBL] [Abstract][Full Text] [Related]
16. Primary aldosteronism in the primary care setting.
Buffolo F; Monticone S; Tetti M; Mulatero P
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):155-159. PubMed ID: 29629943
[TBL] [Abstract][Full Text] [Related]
17. Should all Hypertensive Patients be Screened for Primary Aldosteronism?
Alkagiet S; Tziomalos K
Curr Hypertens Rev; 2019; 15(1):54-56. PubMed ID: 29737255
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
19. Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities.
Turcu AF; Nhan W; Grigoryan S; Zhang L; Urban C; Liu H; Holevinski L; Zhao L
J Am Heart Assoc; 2022 Jul; 11(14):e025952. PubMed ID: 35861830
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Itoh H; Umakoshi H; Tsuiki M; Ichijo T; Katabami T; Tanaka Y; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Okamura S; Miyauchi S; Fukuoka T; Izawa S; Yoneda T; Hashimoto S; Yanase T; Suzuki T; Kawamura T; Tabara Y; Matsuda F; Naruse M; ;
Hypertension; 2018 Mar; 71(3):530-537. PubMed ID: 29358460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
